Evidence map›Paper›PMID 31211696›Full record

ArticleJCI insight2019

Intracellular retention of mutant lysyl oxidase leads to aortic dilation in response to increased hemodynamic stress.

Vivian S Lee, Carmen M Halabi, Thomas J Broekelmann, Philip C Trackman, Nathan O Stitziel, Robert P Mecham

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Sex differences and role of lysyl oxidase-like 2 in angiotensin II-induced hypertension in mice.American journal of physiology. Heart and circulatory physiology · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Vivian S LeeDepartment of Cell Biology and Physiology.
Carmen M HalabiDivision of Nephrology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
Thomas J BroekelmannDepartment of Cell Biology and Physiology.
Philip C TrackmanDepartment of Molecular and Cellular Biology, Boston University, Henry M. Goldman School of Dental Medicine, Boston, Massachusetts, USA.
Nathan O StitzielCardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Robert P MechamDepartment of Cell Biology and Physiology.
Washington University in St. Louis · USBoston University · US

Funding

ASSEMBLY OF LUNG ELASTINR37HL053325 · NHLBI · WASHINGTON UNIVERSITY · PI MECHAM, ROBERT P. · 2000 to 2009
$4.1M
Pediatric Cardiovascular and Pulmonary Research Training Program.T32HL125241 · NHLBI · WASHINGTON UNIVERSITY · PI Juliane Bubeck Wardenburg, Kory J. Lavine · 2015 to 2026
$4.1M
ASSEMBLY OF LUNG ELASTINR01HL053325 · NHLBI · WASHINGTON UNIVERSITY · PI MECHAM, ROBERT P. · 1995 to 2019
$3.6M
ANGPTL3 DEFICIENCY AND ATHEROSCLEROSIS IN HUMANSR01HL131961 · NHLBI · WASHINGTON UNIVERSITY · PI STITZIEL, NATHAN OLIVER · 2016 to 2020
$3.2M
VESSEL STIFFENING, HYPERTENSION, AND VASCULAR EXTRACELLULAR MATRIXR01HL105314 · NHLBI · WASHINGTON UNIVERSITY · PI MECHAM, ROBERT P., WAGENSEIL, JESSICA · 2010 to 2018
$3.2M
Vascular Extracellular Matrix in Arterial Development and DiseaseK08HL135400 · NHLBI · WASHINGTON UNIVERSITY · PI HALABI, CARMEN M. · 2017 to 2020
$613k
Mechanism of Bone Marrow Neoplasm-Induced OsteosclerosisR21AR072748 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAVID, KATYA, TRACKMAN, PHILIP C · 2018 to 2019
$399k
Lysyl Oxidase Mutations in Cardiovascular DiseaseF31HL136073 · NHLBI · WASHINGTON UNIVERSITY · PI LEE-KIM, VIVIAN · 2017 to 2018
$34k
NHLBI NIH HHS F31 HL136073NHLBI NIH HHS K08 HL135400NHLBI NIH HHS R01 HL053325NHLBI NIH HHS R01 HL105314NHLBI NIH HHS R01 HL131961NHLBI NIH HHS R37 HL053325NHLBI NIH HHS T32 HL125241NIAMS NIH HHS R21 AR072748
6 · The paper itself

Abstract

Heterozygous missense mutations in lysyl oxidase (LOX) are associated with thoracic aortic aneurysms and dissections. To assess how LOX mutations modify protein function and lead to aortic disease, we studied the factors that influence the onset and progression of vascular aneurysms in mice bearing a Lox mutation (p.M292R) linked to aortic dilation in humans. We show that mice heterozygous for the M292R mutation did not develop aneurysmal disease unless challenged with increased hemodynamic stress. Vessel dilation was confined to the ascending aorta although both the ascending and descending aortae showed changes in vessel wall structure, smooth muscle cell number and inflammatory cell recruitment that differed between wild-type and mutant animals. Studies with isolated cells found that M292R-mutant Lox is retained in the endoplasmic reticulum and ultimately cleared through an autophagy/proteasome pathway. Because the mutant protein does not transit to the Golgi where copper incorporation occurs, the protein is never catalytically active. These studies show that the M292R mutation results in LOX loss-of-function due to a secretion defect that predisposes the ascending aorta in mice (and by extension humans with similar mutations) to arterial dilation when exposed to risk factors that impart stress to the arterial wall.

Indexed as

AnimalsAortaAortic Aneurysm, ThoracicAortic DissectionCells, CulturedDisease Models, AnimalEmbryo, MammalianEndoplasmic ReticulumExtracellular Matrix ProteinsFibroblastsGene Knock-In TechniquesGenetic Predisposition to DiseaseGolgi ApparatusHeterozygoteHumansHypertensionExtracellular Matrix ProteinsLox protein, mouseProtein-Lysine 6-OxidaseCell BiologyCollagensExtracellular matrixMouse modelsVascular Biology

Identifiers

PMID31211696
PMCPMC6693828
OpenAlexW2950028168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.